200 related articles for article (PubMed ID: 9986765)
41. Proton spectroscopy of brain glutamine in acute liver failure.
McConnell JR; Antonson DL; Ong CS; Chu WK; Fox IJ; Heffron TG; Langnas AN; Shaw BW
Hepatology; 1995 Jul; 22(1):69-74. PubMed ID: 7601435
[TBL] [Abstract][Full Text] [Related]
42. Broadband decoupled, 1H-localized 13C MRS of the human brain at 4 Tesla.
Gruetter R; Adriany G; Merkle H; Andersen PM
Magn Reson Med; 1996 Nov; 36(5):659-64. PubMed ID: 8916015
[TBL] [Abstract][Full Text] [Related]
43. [1-13C]glucose MRS in chronic hepatic encephalopathy in man.
Blüml S; Moreno-Torres A; Ross BD
Magn Reson Med; 2001 Jun; 45(6):981-93. PubMed ID: 11378875
[TBL] [Abstract][Full Text] [Related]
44. Which prior knowledge? Quantification of in vivo brain 13C MR spectra following 13C glucose infusion using AMARES.
Lanz B; Duarte JM; Kunz N; Mlynárik V; Gruetter R; Cudalbu C
Magn Reson Med; 2013 Jun; 69(6):1512-22. PubMed ID: 22886985
[TBL] [Abstract][Full Text] [Related]
45. Selective proton-observed, carbon-edited (selPOCE) MRS method for measurement of glutamate and glutamine
De Feyter HM; Herzog RI; Steensma BR; Klomp DWJ; Brown PB; Mason GF; Rothman DL; de Graaf RA
Magn Reson Med; 2018 Jul; 80(1):11-20. PubMed ID: 29134686
[TBL] [Abstract][Full Text] [Related]
46. Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRI.
Janson CG; McPhee SW; Francis J; Shera D; Assadi M; Freese A; Hurh P; Haselgrove J; Wang DJ; Bilaniuk L; Leone P
Neuropediatrics; 2006 Aug; 37(4):209-21. PubMed ID: 17177147
[TBL] [Abstract][Full Text] [Related]
47. In vivo 3D localized 13C spectroscopy using modified INEPT and DEPT.
Watanabe H; Ishihara Y; Okamoto K; Oshio K; Kanamatsu T; Tsukada Y
J Magn Reson; 1998 Oct; 134(2):214-22. PubMed ID: 9761697
[TBL] [Abstract][Full Text] [Related]
48. Reduced cortical thickness in patients with acute-on-chronic liver failure due to non-alcoholic etiology.
Yadav SK; Gupta RK; Saraswat VA; Rangan M; Thomas MA; Rutella S; Danese S; Wang E; Marincola FM; Haris M
J Transl Med; 2015 Oct; 13():322. PubMed ID: 26444271
[TBL] [Abstract][Full Text] [Related]
49. Magnetic resonance imaging in juvenile Canavan disease.
Toft PB; Geiss-Holtorff R; Rolland MO; Pryds O; Müller-Forell W; Christensen E; Lehnert W; Lou HC; Ott D; Hennig J
Eur J Pediatr; 1993 Sep; 152(9):750-3. PubMed ID: 8223809
[TBL] [Abstract][Full Text] [Related]
50. Four-and-one-half years' experience in monitoring of reproducibility of an MR spectroscopy system--application of in vitro results to interpretation of in vivo data.
Skorupa A; Wicher M; Banasik T; Jamroz E; Paprocka J; Kiełtyka A; Sokół M; Konopka M
J Appl Clin Med Phys; 2014 May; 15(3):323–334. PubMed ID: 24892353
[TBL] [Abstract][Full Text] [Related]
51. Measurement of glucose metabolism in the occipital lobe and frontal cortex after oral administration of [1-13C]glucose at 9.4 T.
Ziegs T; Dorst J; Ruhm L; Avdievitch N; Henning A
J Cereb Blood Flow Metab; 2022 Oct; 42(10):1890-1904. PubMed ID: 35632989
[TBL] [Abstract][Full Text] [Related]
52. Age-related glutamate and glutamine concentration changes in normal human brain: 1H MR spectroscopy study at 4 T.
Kaiser LG; Schuff N; Cashdollar N; Weiner MW
Neurobiol Aging; 2005 May; 26(5):665-72. PubMed ID: 15708441
[TBL] [Abstract][Full Text] [Related]
53. Accuracy of 2-hydroxyglutarate quantification by short-echo proton-MRS at 3 T: a phantom study.
Bertolino N; Marchionni C; Ghielmetti F; Burns B; Finocchiaro G; Anghileri E; Bruzzone MG; Minati L
Phys Med; 2014 Sep; 30(6):702-7. PubMed ID: 24685182
[TBL] [Abstract][Full Text] [Related]
54. 1-(13)C glucose magnetic resonance spectroscopy of pediatric and adult brain disorders.
Blüml S; Moreno A; Hwang JH; Ross BD
NMR Biomed; 2001 Feb; 14(1):19-32. PubMed ID: 11252037
[TBL] [Abstract][Full Text] [Related]
55. Automated data processing of [1H-decoupled] 13C MR spectra acquired from human brain in vivo.
Shic F; Ross B
J Magn Reson; 2003 Jun; 162(2):259-68. PubMed ID: 12810010
[TBL] [Abstract][Full Text] [Related]
56. Quantitative measurements with localized 1H MR spectroscopy in children with Canavan's disease.
Wittsack HJ; Kugel H; Roth B; Heindel W
J Magn Reson Imaging; 1996; 6(6):889-93. PubMed ID: 8956134
[TBL] [Abstract][Full Text] [Related]
57. Localized in vivo human 1H MRS at very short echo times.
Zhong K; Ernst T
Magn Reson Med; 2004 Oct; 52(4):898-901. PubMed ID: 15389966
[TBL] [Abstract][Full Text] [Related]
58. [Magnetic resonance spectroscopy of metabolic changes in mice brain after 2-deoxy-D-glucose injection].
Moshkin MP; Akulov AE; Petrovskiĭ DV; Saĭk OV; Petrovskiĭ ED; Savelov AA; Koptug IV
Ross Fiziol Zh Im I M Sechenova; 2012 Oct; 98(10):1264-72. PubMed ID: 23401921
[TBL] [Abstract][Full Text] [Related]
59. Investigation of NAA and NAAG dynamics underlying visual stimulation using MEGA-PRESS in a functional MRS experiment.
Landim RC; Edden RA; Foerster B; Li LM; Covolan RJ; Castellano G
Magn Reson Imaging; 2016 Apr; 34(3):239-45. PubMed ID: 26656908
[TBL] [Abstract][Full Text] [Related]
60. Refined modelling of the short-T2 signal component and ensuing detection of glutamate and glutamine in short-TE, localised, (1) H MR spectra of human glioma measured at 3 T.
Gottschalk M; Troprès I; Lamalle L; Grand S; Le Bas JF; Segebarth C
NMR Biomed; 2016 Jul; 29(7):943-51. PubMed ID: 27197077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
